AGIOS PHARMACEUTICALS, INC. Other Receivables, Net, Current
AGIOS PHARMACEUTICALS, INC. (AGIO) had Other Receivables, Net, Current of $3.77 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › and Others › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2022-11-03
- 2022-09-30: Other Receivables, Net, Current $3.77M.
- 2022-06-30: Other Receivables, Net, Current $2.70M.
- 2022-03-31: Other Receivables, Net, Current $5.37M.
- 2021-12-31: Other Receivables, Net, Current $4.38M.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2022-09-30 | $3.77M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.37M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.38M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $6.99M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $8.13M 10-Q · filed 2021-07-29 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-03 |
| 2014-12-31 | $2.33M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |